These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 33358862)
1. Effect of the enzyme replacement therapy on hypertrophic cardiomyopathy in an infant with the CRIM-negative infantile Pompe's disease. Vaksmann G; Guemann AS; Mention K Pediatr Neonatol; 2021 May; 62(3):333-334. PubMed ID: 33358862 [No Abstract] [Full Text] [Related]
2. Enzyme replacement therapy in an infant with Pompe's disease with severe cardiomyopathy. Tanzer F; Buyukkayhan D; Cansu Mutlu E; Kalender Korkmaz F J Pediatr Endocrinol Metab; 2009 Dec; 22(12):1159-62. PubMed ID: 20333876 [TBL] [Abstract][Full Text] [Related]
3. Enzyme replacement therapy for infantile Pompe disease during the critical period and identification of a novel mutation. But WM; Lee SH; Chan AO; Lau GT Hong Kong Med J; 2009 Dec; 15(6):474-7. PubMed ID: 19966354 [TBL] [Abstract][Full Text] [Related]
4. [Enzyme replacement therapy in Pompe's disease]. Merk T; Wibmer T; Schumann C; Krüger S Med Klin (Munich); 2007 Jul; 102(7):570-3. PubMed ID: 17634875 [TBL] [Abstract][Full Text] [Related]
5. Morphological changes in muscle tissue of patients with infantile Pompe's disease receiving enzyme replacement therapy. Winkel LP; Kamphoven JH; van den Hout HJ; Severijnen LA; van Doorn PA; Reuser AJ; van der Ploeg AT Muscle Nerve; 2003 Jun; 27(6):743-51. PubMed ID: 12766987 [TBL] [Abstract][Full Text] [Related]
6. In Utero Enzyme-Replacement Therapy for Infantile-Onset Pompe's Disease. Cohen JL; Chakraborty P; Fung-Kee-Fung K; Schwab ME; Bali D; Young SP; Gelb MH; Khaledi H; DiBattista A; Smallshaw S; Moretti F; Wong D; Lacroix C; El Demellawy D; Strickland KC; Lougheed J; Moon-Grady A; Lianoglou BR; Harmatz P; Kishnani PS; MacKenzie TC N Engl J Med; 2022 Dec; 387(23):2150-2158. PubMed ID: 36351280 [TBL] [Abstract][Full Text] [Related]
7. [Clinical manifestations, course and outcome of enzyme replacement therapy in Hungarian patients with Pompe's disease]. Bereznai B; Trauninger A; György I; Szakszon K; Almássy Z; Pál E; Herczegfalvi A; Várdi Visy K; Illés Z; Molnár MJ Orv Hetil; 2011 Sep; 152(39):1569-75. PubMed ID: 21920843 [TBL] [Abstract][Full Text] [Related]
8. Enzyme therapy and immune response in relation to CRIM status: the Dutch experience in classic infantile Pompe disease. van Gelder CM; Hoogeveen-Westerveld M; Kroos MA; Plug I; van der Ploeg AT; Reuser AJ J Inherit Metab Dis; 2015 Mar; 38(2):305-14. PubMed ID: 24715333 [TBL] [Abstract][Full Text] [Related]
10. Apical Hypertrophic Cardiomyopathy in an Infant: First Presentation of Pompe's Disease. Patra S; Subramaniun A; Mahimaiha J; Sastry UM; Nanjappa MC World J Pediatr Congenit Heart Surg; 2014 Jul; 5(3):491-3. PubMed ID: 24958062 [TBL] [Abstract][Full Text] [Related]
11. Recombinant human alpha-glucosidase from rabbit milk in Pompe patients. Van den Hout H; Reuser AJ; Vulto AG; Loonen MC; Cromme-Dijkhuis A; Van der Ploeg AT Lancet; 2000 Jul; 356(9227):397-8. PubMed ID: 10972374 [TBL] [Abstract][Full Text] [Related]
12. When should we start enzyme replacement therapy for infantile Pompe disease with severe cardiomyopathy? Bonilla-Palomas JL; Gámez-López AL; Tejero-Hernández MA; Tejero-Mateo I; López-López J Rev Esp Cardiol (Engl Ed); 2012 Jan; 65(1):100-2. PubMed ID: 21715078 [No Abstract] [Full Text] [Related]
18. Enzyme replacement therapy in late-onset Pompe's disease: a three-year follow-up. Winkel LP; Van den Hout JM; Kamphoven JH; Disseldorp JA; Remmerswaal M; Arts WF; Loonen MC; Vulto AG; Van Doorn PA; De Jong G; Hop W; Smit GP; Shapira SK; Boer MA; van Diggelen OP; Reuser AJ; Van der Ploeg AT Ann Neurol; 2004 Apr; 55(4):495-502. PubMed ID: 15048888 [TBL] [Abstract][Full Text] [Related]
19. Elimination of antibodies to recombinant enzyme in Pompe's disease. Mendelsohn NJ; Messinger YH; Rosenberg AS; Kishnani PS N Engl J Med; 2009 Jan; 360(2):194-5. PubMed ID: 19129538 [No Abstract] [Full Text] [Related]
20. Cardiac remodeling after enzyme replacement therapy with acid alpha-glucosidase for infants with Pompe disease. Levine JC; Kishnani PS; Chen YT; Herlong JR; Li JS Pediatr Cardiol; 2008 Nov; 29(6):1033-42. PubMed ID: 18661169 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]